{"version":"1.0","type":"link","title":"The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [18F] fluorodeoxyglucose PET.","author_name":"Lenaerts M 외","author_url":"https://prs-insight.online/author/Lenaerts%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/84175","thumbnail_width":1200,"thumbnail_height":630}